Info
Insider Trading
Financials
Holders

Insider Transactions Reported by 10 Insiders of Quoin Pharmaceuticals, Ltd.

Symbol: QNRX on Nasdaq
Location: Kfar Saba

Insiders trading volume in the past year

	Insiders	Shares	%	Avg Price	Total $
Buys	1	+15,152	100%	$8.49	+$128,640
Sells	0
Net	+1	+15,152	100%		+$128,640

Quoin Pharmaceuticals, Ltd. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Stonepine Capital Management, LLC	10%+ Owner	$47,201,973			29 Jan 2026
Dennis Langer	Director	$128,648	+$128,640	+1608000%	04 Feb 2026
Gordon Dunn	Chief Financial Officer	$67,985			23 Dec 2024
Sally Bridget Lawlor	Chief Financial Officer				04 Feb 2026
Michael Sember	Director				04 Feb 2026
Natalie Leong	Director				04 Feb 2026
Michael Myers	Chief Executive Officer, Director				04 Feb 2026
Anthony James Culverwell	Director				04 Feb 2026
Denise Carter	Chief Operating Officer, Director				04 Feb 2026
Joseph Cooper	Director				04 Feb 2026

Recent Insider Transactions by Companies or Individuals for Quoin Pharmaceuticals, Ltd.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.